The Since gallium is a bone-seeking element (1-3), radionuclides of this element have been of clinical interest as diagnostic screening agents of bone tumors. In 1969 Edwards and Hayes (4) noted that carrier-free gallium-67 citrate was localized in addition in nonosseous tumors in patients with Hodgkin's disease and other lyinphomas. Deposition of this radioactive salt was also observed in patients with other "soft-tissue", slow-growing tumors (4-8), such as poorly differentiated thyroid adenocarcinoma, reticulum cell sarcoma, lymphosarcoma, and carcinomas of the lung, breast, colon, and kidney. These unexpected observations prompted studies on the concentration of this gallium radionuclide in various experimental animal tumors. Seven nonosseous rat and mouse carcinomas and sarcomas showed variable but distinct localization of 67Ga, in contrast to deposition in normal tissues (9). In addition, the Cancer Chemotherapy National Service Center has found that gallium nitrate possessed antitumor activity against Walker 256 carcinosarcoma in rats. These observations prompted us to examine the antitumor activity of gallium and metal salts chemically related to gallium. In increasing order of atomic numbers and atomic weight, the elements of Group lila of the periodic table are boron (B), aluminum (Al), gallium (Ga), indium (In), and thallium (Tl). The +3 oxidation state of these elements as cations is the most stable form in aqueous solution, except for thallium +3 which is slowly converted to the +1 form. The +3 forms of these elements were used in our experiments. We were unable to obtain a stable cationic
TlCI, > ln(NO3)3 > Ga(NO3)3 > Al(NO3)3. All four metals exhibited antitumor activity, but when the tumor was inoculated by a route different from that of the drug, only Ga+3 and, to a lesser extent, In +3 inhibited tumor growth.
Ga(NO3)s was found to inhibit the growth of three out of four rodent solid tumors. Gallium therefore has potential therapeutic usefulness for treatment of solid tumors inl man.
Since gallium is a bone-seeking element (1-3), radionuclides of this element have been of clinical interest as diagnostic screening agents of bone tumors. In 1969 Edwards and Hayes (4) noted that carrier-free gallium-67 citrate was localized in addition in nonosseous tumors in patients with Hodgkin's disease and other lyinphomas. Deposition of this radioactive salt was also observed in patients with other "soft-tissue", slow-growing tumors (4) (5) (6) (7) (8) , such as poorly differentiated thyroid adenocarcinoma, reticulum cell sarcoma, lymphosarcoma, and carcinomas of the lung, breast, colon, and kidney. These unexpected observations prompted studies on the concentration of this gallium radionuclide in various experimental animal tumors. Seven nonosseous rat and mouse carcinomas and sarcomas showed variable but distinct localization of 67Ga, in contrast to deposition in normal tissues (9) . In addition, the Cancer Chemotherapy National Service Center has found that gallium nitrate possessed antitumor activity against Walker 256 carcinosarcoma in rats. These observations prompted us to examine the antitumor activity of gallium and metal salts chemically related to gallium.
In increasing order of atomic numbers and atomic weight, the elements of Group lila of the periodic table are boron (B), aluminum (Al), gallium (Ga), indium (In), and thallium (Tl). The +3 oxidation state of these elements as cations is the most stable form in aqueous solution, except for thallium +3 which is slowly converted to the +1 form. The +3 forms of these elements were used in our experiments. We were unable to obtain a stable cationic form of +3 boron, and the only stable soluble form of +3
Tl was the trichloride.
The experiments reported here were designed to determine the toxicitv of various Group I11a salts in two species, the CDF, mouse and the Sprague-Dawley rat; to test nontoxic doses of these salts for antitumor activity against two experimental rodent tumors with a high clinical predictability value (10) ; to attempt to correlate the in vivo activity of these salts and their in vitro action in tissue culture; and to assess the antitumor activity of the active salt against various rodent solid tumors.
MATERIALS AND METHODS
Adult male CDF, mice (NIH) colony), 20-27 g, and adult female Sprague-Dawley rats (NIH colony), 120-150 g, were randomly divided into groups and used for all in vivo experiments.
Tumors
The mice were inoculated intraperitoneally with 0.1 ml of a 1:1000 dilution of leukemia L1210 ascitic fluid in Locke's solution. The In vivo antitumor activity against ascitic tumors Table 2 shows that all four salts increased the median survival time of Sprague-Dawley rats carrying the ascitic form of Walker 256 carcinosarcoma. The number and percentage of long-term survivors (defined as rats that lived for 4 months after tumor inoculation and showed no evidence of tumor at autopsy) was highest for aluminum nitrate ( Table 2 ). The antitumor activity in vivo of these four salts against The concentration of each compound in the culture medium listed in Table 4 is equivalent to that in the intact animal at the described intraperitoneal dosage level if these salts are distributed to total body water. The decreasing order of growth inhibition of these salts against the Walker 256 cells, Tl > Al > Ga > In, is identical to the order of decreasing percentage median survival times of rats carrying the tumor. Drug concentrations at these levels (approximately the LDjo) had little or no effect on L1210 cells in tissue culture and did not increase the percentage median survival time of mice carrying ascitic L1210. These data suggest a reason for the lack of in vivo activity of these salts against L1210, i.e., the dose necessary for L1210 growth inhibition is toxic to the animal.
Effect of route of tumor inoculation and drug administration on antitumor effect of Group III salts against Walker 256 carcinosarcoma When the same doses of Group III salts effective against the ascitic Walker 256 carcinosarcoma were administered to rats carrying the subcutaneous form of this tumor, the results outlined in Table 5 were obtained. In this situation In(NO3)3*5H20 Proc. Nat. Acad. Sci. USA 68 (1971) culture. When these compounds were injected intraperitoneally into animals carrying the ascitic form of W256 and L1210, the order of antitumor activity against W256 was identical to that seen in tissue culture, namely Tl > Al > Ga > In. None of the four compounds produced any activity against ascitic leukemia L1210 when the drug was injected intraperitoneally. A possible explanation for the lack of in vivo activity of these four salts against leukemia L1210 is that the concentration necessary for growth inhibition in tissue culture is toxic when injected intraperitoneally into the mouse.
When the drugs were not injected directly into the body compartment occupied by the tumor, the order of effectiveness against the Walker carcinosarcoma changed. Only Ga(NO3)3
and In(NO3)3 are effective when injected at a site differing from that of the tumor. Gallium is the most effective in this regard, apparently because the ion is sequestered by the tumor from the blood stream.
The anionic component of the metallic salt did not influence the antitumor activity. Thus, the chlorides and sulfates of aluminum, gallium, and indium were equivalent in activity to their respective nitrates. Preliminary experiments have shown that not only gallium, but also indium and in some cases aluminum salts prevent the growth of various experimental solid tumors. We are currently continuing our studies of the antitumor activity of these and other inorganic salts against various transplantable rodent tumors and are attempting to correlate their uptake with their antitumor activity. Not only are gallium salts taken up by solid tumors, but they have now been shown -to possess antitumor activity. Gallium therefore has potential therapeutic usefulness for treatment of solid tumors in man. Perhaps an even greater benefit to the patients with gallium-sequestering solid tumors could be derived by attaching other cytotoxic agents (i.e., nitrogen mustards) to one or more of the ligand bonds available on the gallium atom. We are also currently investigating this possibility.
